ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000243243.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.039909309	Resistant
ENSG00000243243.1	ABT-263 (navitoclax)	Ovarian serous cyStomach adenocarcinomaenocarcinoma	0.02934958	Resistant